Water for dialysis and bicarbonate dialysate are regularly contaminated wit
h Gramnegative bacteria, endotoxin and other bacterial products. The degree
of contamination exceeds recommended standards of dialysate quality in 20%
of tested samples. Several in vitro studies have demonstrated that small-m
olecular-weight substances of bacterial origin (pyrogens) derived from cont
aminated dialysate are able to penetrate intact dialyzer membranes and to i
nduce the production and release of proinflammtory cytokines in circulating
mononuclear cells. Because complement enhances pyrogen-induced cytokine pr
oduction, the risk of hemodialysis-associated cytokine induction is highest
when contaminated dialysate is used in combination with pyrogen-permeable
and complement-activating dialyzer membranes. Acute consequences of hemodia
lysis-associated induction of IL-1 beta and TNF alpha are elevated plasma l
evels of acute-phase-proteins (such as CRP), prostaglandins (such as PGE(2)
) and NO, which dependent on the magnitude of the acute-phase response may
induce fever, cardiovascular instability and edema (lung edema). In additio
n, there are chronic inflammatory diseases associated with long-term hemodi
alysis therapy in which proinflammatory mediators such as IL-1 beta and TNF
a are thought to play an important role. These diseases include beta 2-M am
yloidosis, catabolic muscle protein degradation, and possibly also arterios
clerosis. The goal in modern hemodialysis therapy should be to reduce treat
ment-dependent cytokine induction by improving the bacteriological quality
of dialysate. It is hoped that thereby dialysis-associated diseases will be
less severe or even prevented.